Suppr超能文献

基于淋巴结比率的分期系统与第 7 版 AJCC 系统在胃癌中的比较:来自 SEER 数据库的 18043 例患者的分析。

Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database.

机构信息

Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Ann Surg. 2012 Mar;255(3):478-85. doi: 10.1097/SLA.0b013e31824857e2.

Abstract

OBJECTIVES

The American Joint Committee on Cancer (AJCC) staging system for gastric cancer bases N status on absolute number of metastatic nodes, regardless of the number of examined nodes. We examined a modified staging system utilizing node ratio (Nr), the ratio of metastatic to examined nodes.

METHODS

A total of 18,043 gastric cancer patients who underwent gastrectomy were identified from the US Surveillance, Epidemiology, and End Results (SEER) database. A training set was divided into 5 Nr groups, and a TNrM staging system was constructed. Median survival and overall survival, based on 7th edition AJCC and TNrM staging systems, were compared, and the analysis was repeated in a validation set.

RESULTS

Median examined nodes were 10 to 11. For the training set, overall survival for all 5 AJCC N categories was significantly different when subgrouped into 15 or fewer versus more than 15 examined nodes, but overall survival was similar regardless of the number of examined nodes in 4 of 5 Nr categories. Seven AJCC stages had statistically different overall survival between subgroups, whereas only 1 TNrM stage had statistically different overall survival between subgroups. When misclassification was defined as any subgroup in which median survival fell outside the 95% confidence interval of the group's overall median survival, AJCC staging misclassified 57% of patients and TNrM staging misclassified only 12%. Similar results were found in the validation set.

CONCLUSIONS

The AJCC system classifies SEER gastric cancer patients into stages in which subgroups often have wide variations in survival. For patients undergoing limited lymph node analysis, the proposed TNrM system may predict survival more accurately.

摘要

目的

美国癌症联合委员会(AJCC)的胃癌分期系统将 N 状态基于转移淋巴结的绝对数量,而不考虑检查的淋巴结数量。我们研究了一种利用淋巴结比值(Nr)的改良分期系统,即转移淋巴结与检查淋巴结的比值。

方法

从美国监测、流行病学和最终结果(SEER)数据库中确定了 18043 例接受胃切除术的胃癌患者。将一个训练集分为 5 个 Nr 组,并构建了一个 TNrM 分期系统。根据第 7 版 AJCC 和 TNrM 分期系统,比较了中位生存期和总生存期,并在验证集中重复了该分析。

结果

中位检查淋巴结为 10 到 11 个。对于训练集,当根据 15 个或更少与超过 15 个检查淋巴结将所有 5 个 AJCC N 类别分组时,所有类别的总生存期均有显著差异,但在 5 个 Nr 类别中的 4 个类别中,无论检查淋巴结的数量如何,总生存期相似。7 个 AJCC 分期在亚组之间的总生存期有统计学差异,而只有 1 个 TNrM 分期在亚组之间的总生存期有统计学差异。当将错误分类定义为中位生存期落在组总中位生存期 95%置信区间之外的任何亚组时,AJCC 分期错误分类了 57%的患者,而 TNrM 分期仅错误分类了 12%。在验证集中也发现了类似的结果。

结论

AJCC 系统将 SEER 胃癌患者分为分期,其中亚组的生存期差异很大。对于接受有限淋巴结分析的患者,所提出的 TNrM 系统可能更准确地预测生存。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验